ArticleJournal for immunotherapy of cancer2021

Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma.

Troels Holz Borch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.